October 23, 2017
Wilson Therapeutics reaches agreement with the FDA and EMA to initiate pivotal Phase 3 FOCuS study with WTX101 in Wilson Disease
Media
October 20, 2017
Promising preliminary long-term data for WTX101 in Wilson Disease highlighted at The Liver Meeting®
October 19, 2017
BONESUPPORT HOLDING AB (publ) – Q3 2017 Interim Report – invitation to conference call and webcast
October 17, 2017
Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm
October 16, 2017
Aprea Therapeutics Announces First Patients Enrolled in Phase Ib/II Clinical Study of APR-246 for the Treatment of Esophageal Cancer
October 16, 2017
Nexstim Plc is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US
October 16, 2017
GenSight Biologics to Present Data on GS010 and GS030 at the 2017 Congress of the European Society of Gene & Cell Therapy
October 12, 2017
Change in Nexstim Plc’s Management Team
October 12, 2017
Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
October 06, 2017
Phase 2 Clinical Trial Data for WTX101 Published in The Lancet Gastroenterology & Hepatology